|Articles|March 18, 2021
WP: SEC-MALS for Absolute Biophysical Characterization
Author(s)Wyatt Technology
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
Cellares Extends Cell Therapy Automation Beyond T Cell Therapies
3
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5